REN and Hyperglycemia: In overweight patients, MAO contributes to cardiac oxidative stress in basal conditions and those that mimicked the renin–angiotensin system activation and hyperglycemia and can be targeted with empagliflozin and dapagliflozin, as novel off-target class effect of the SGLT2i.